Identification of the E3 deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a positive regulator of the transcription factor GATA3

Journal of Biological Chemistry

Volumn 288, Issue 13, 2013, Pages 9373-9382

  Zhang, Jing ^a   Chen, Chen ^a   Hou, Xiaoxia ^b   Gao, Yayi ^a   Lin, Fang ^a   Yang, Jing ^a   Gao, Zhimei ^a   Pan, Lina ^b   Tao, Lianqin ^b   Wen, Chijun ^c   Yao, Zhengju ^a   Tsun, Andy ^a   Shi, Guochao ^b   Li, Bin ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Second People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOWN-REGULATION; GENE PROMOTER; INFLAMMATORY RESPONSE; PHYSIOLOGICAL FUNCTIONS; PROTEIN EXPRESSIONS; T-CELL RECEPTORS; TREG CELLS; UP-REGULATION;

CELL CULTURE; CELL MEMBRANES; PHYSIOLOGICAL MODELS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

CELL SIGNALING;

PEPTIDASE; SHORT HAIRPIN RNA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; UBIQUITIN SPECIFIC PEPTIDASE 21; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GATA 3 GENE; GENE; GENE TARGETING; HUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UBIQUITIN SPECIFIC PEPTIDASE 21 GENE; UBIQUITINATION; UPREGULATION;

ADOLESCENT; ADULT; ASTHMA; CELL LINE, TUMOR; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES; UBIQUITIN THIOLESTERASE;

EID: 84875979211     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.374744     Document Type: Article

References (35)

1. Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008) Regulatory T cells and immune tolerance. Cell 133, 775-787
2. Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336
3. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., Ziegler, S. F., and Littman, D. R. (2008) TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγt function. Nature 453, 236-240
4. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., and Campbell, D. J. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602
5. Wang, Y., Souabni, A., Flavell, R. A., and Wan, Y. Y. (2010) An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo. J. Immunol. 185, 5983-5992
6. Zhu, J., Min, B., Hu-Li, J., Watson, C. J., Grinberg, A., Wang, Q., Killeen, N., Urban, J. F., Jr., Guo, L., and Paul, W. E. (2004) Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5, 1157-1165
7. Zheng, W., and Flavell, R. A. (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596
8. Wang, L., Wildt, K. F., Zhu, J., Zhang, X., Feigenbaum, L., Tessarollo, L., Paul, W. E., Fowlkes, B. J., and Bosselut, R. (2008) Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells. Nat. Immunol. 9, 1122-1130
9. Pandolfi, P. P., Roth, M. E., Karis, A., Leonard, M. W., Dzierzak, E., Grosveld, F. G., Engel, J. D., and Lindenbaum, M. H. (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11, 40-44
10. Mantel, P. Y., Kuipers, H., Boyman, O., Rhyner, C., Ouaked, N., Rückert, B., Karagiannidis, C., Lambrecht, B. N., Hendriks, R. W., Crameri, R., Akdis, C. A., Blaser, K., and Schmidt-Weber, C. B. (2007) GATA3-driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 5, e329
11. Wei, J., Duramad, O., Perng, O. A., Reiner, S. L., Liu, Y. J., and Qin, F. X. (2007) Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 104, 18169-18174
12. Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I. C., Khoury, S., Oukka, M., and Kuchroo, V. K. (2008) IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+IL-10+Foxp3(-) effector T cells. Nat. Immunol. 9, 1347-1355
13. Wang, Y., Su, M. A., and Wan, Y. Y. (2011) An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337-348
14. Wohlfert, E. A., Grainger, J. R., Bouladoux, N., Konkel, J. E., Oldenhove, G., Ribeiro, C. H., Hall, J. A., Yagi, R., Naik, S., Bhairavabhotla, R., Paul, W. E., Bosselut, R., Wei, G., Zhao, K., Oukka, M., Zhu, J., and Belkaid, Y. (2011) GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503-4515
15. Xiao, Y., Li, B., Zhou, Z., Hancock, W. W., Zhang, H., and Greene, M. I. (2010) Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Curr. Opin Immunol. 22, 583-591
16. Li, B., Samanta, A., Song, X., Iacono, K. T., Bembas, K., Tao, R., Basu, S., Riley, J. L., Hancock, W. W., Shen, Y., Saouaf, S. J., and Greene, M. I. (2007) FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. U.S.A. 104, 4571-4576
17. Hershko, A., and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479
18. Sun, S. C. (2008) Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8, 501-511
19. Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., Sixma, T. K., and Bernards, R. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786
20. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., Ma, A., Koonin, E. V., and Dixit, V. M. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699
21. Enesa, K., Zakkar, M., Chaudhury, H., Luong le, A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L., and Evans, P. C. (2008) NF-κB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 283, 7036-7045
22. Tzimas, C., Michailidou, G., Arsenakis, M., Kieff, E., Mosialos, G., and Hatzivassiliou, E. G. (2006) Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-κB. Cell Signal 18, 83-92
23. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M., and Bernards, R. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801
24. Schweitzer, K., Bozko, P. M., Dubiel, W., and Naumann, M. (2007) CSN controls NF-κB by deubiquitinylation of IκBα. EMBO J. 26, 1532-1541
25. Xu, G., Tan, X., Wang, H., Sun, W., Shi, Y., Burlingame, S., Gu, X., Cao, G., Zhang, T., Qin, J., and Yang, J. (2010) Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor α-induced nuclear factor κB activation via binding to and deubiquitinating receptor-interacting protein 1. J. Biol. Chem. 285, 969-978
26. Yuan, J., Luo, K., Zhang, L., Cheville, J. C., and Lou, Z. (2010) USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140, 384-396
27. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., and Gu, W. (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653
28. Grainger, J. R., Smith, K. A., Hewitson, J. P., McSorley, H. J., Harcus, Y., Filbey, K. J., Finney, C. A., Greenwood, E. J., Knox, D. P., Wilson, M. S., Belkaid, Y., Rudensky, A. Y., and Maizels, R. M. (2010) Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-βpathway. J. Exp. Med. 207, 2331-2341
29. Sowa, M. E., Bennett, E. J., Gygi, S. P., and Harper, J. W. (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403
30. Chapoval, S., Dasgupta, P., Dorsey, N. J., and Keegan, A. D. (2010) Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J. Leukoc Biol. 87, 1011-1018
31. Wei, G., Abraham, B. J., Yagi, R., Jothi, R., Cui, K., Sharma, S., Narlikar, L., Northrup, D. L., Tang, Q., Paul, W. E., Zhu, J., and Zhao, K. (2011) Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35, 299-311
32. Karagiannidis, C., Akdis, M., Holopainen, P., Woolley, N. J., Hense, G., Rückert, B., Mantel, P. Y., Menz, G., Akdis, C. A., Blaser, K., and Schmidt-Weber, C. B. (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114, 1425-1433
33. Rudra, D., deRoos, P., Chaudhry, A., Niec, R. E., Arvey, A., Samstein, R. M., Leslie, C., Shaffer, S. A., Goodlett, D. R., and Rudensky, A. Y. (2012) Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 13, 1010-1019
34. Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., and Rudensky, A. Y. (2010) Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671
35. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martínez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., and Bluestone, J. A. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007